{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0032716/OMIM:618384","label":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","mondoId":"MONDO:0032716","onsetQualifier":null,"recordKeys":["1a49f6c3b4954648a74cc3bfb2b3354254a4a9ca1c154f006cad4d9b538c040f","3fcdb4a8d2eaf8e3e1d01788caca51d3d4bc28099a54897edce949fc031ab1c3","423213a527909ece384967901238f0558d7126aedbcce0c95a17936841fdddcf","4306926e56548a134813df760ad9f6fe6a45c49a0068407c182c0cb975c5c23c","53234bb1efb1d0f83968d2fd6c2e591d2edf703814375f7a8a559cf829d4ce57","634154f6ed08f98bb66d481c74f9f7897d8be2b65ea1967c024daad2bdefd44c","7498b3351437916161c8b466f09dfbcc055faa687e3b86f8d48c01b847ce7000","75de04a6092744fd8bcebed8ccdab1b4f64bf5200dc193248efa892b5570398f","8c2ecb7f2ddda9f4ae134a329a8d7e3383cb7be325675e096d819f152a430b20","a1dc554c73121f8ae97b2fc1dca3d4758d97fceaa48ae0ccf3f32420ab390fed","b588d22d32accff4fc4b0da30e83db21bbdf2c75d0f4fb98db51edc08b11480c","be2732e1a8e5ebc5295c6b3ba266f44313c9585bb7e0f1d63d535bde1bff5f0a","c8ba2a974d689e4abc20a2e1cd0e4b80b8cca38bf9f06c8fb3a49b089c320ddd","cfbcb0e76aa745f5f4d33970d35d7e105035376c6798e6e96fc1c6508b3029ca","e9275794122574bff7707d8c9c70e4c6c57eeceea093b9f7a16bb3cf2258ad5f"],"recordQualifiers":{},"scopeLabel":"OMIM:618384","sourceIds":["OMIM:618384"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0032716/OMIM:618384"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":15,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":15,"sourceGroups":{"omim":0,"orphanet":0,"published":15}},"features":[{"hpoId":"HP:0002500","label":"Abnormal cerebral white matter morphology","primary":false},{"hpoId":"HP:0001251","label":"Ataxia (coordination difficulty)","primary":false},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":false},{"hpoId":"HP:0012229","label":"CSF pleocytosis","primary":false},{"hpoId":"HP:0002329","label":"Drowsiness","primary":false},{"hpoId":"HP:0001260","label":"Dysarthria","primary":false},{"hpoId":"HP:0001310","label":"Dysmetria","primary":false},{"hpoId":"HP:6000468","label":"Elevated CSF alpha-ketoglutarate concentration","primary":false},{"hpoId":"HP:0034649","label":"Elevated urine N-acetylaspartic acid level","primary":false},{"hpoId":"HP:0002373","label":"Febrile seizure (within the age range of 3 months to 6 years)","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0002490","label":"Increased CSF lactate","primary":false},{"hpoId":"HP:0012402","label":"Increased urine alpha-ketoglutarate concentration","primary":false},{"hpoId":"HP:0033092","label":"Increased urine succinate level","primary":false},{"hpoId":"HP:0002344","label":"Progressive neurologic deterioration","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0032716","records":[{"frequencyKind":"count","key":"1a49f6c3b4954648a74cc3bfb2b3354254a4a9ca1c154f006cad4d9b538c040f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3fcdb4a8d2eaf8e3e1d01788caca51d3d4bc28099a54897edce949fc031ab1c3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002373","is_excluded":false,"label":"Febrile seizure (within the age range of 3 months to 6 years)","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"423213a527909ece384967901238f0558d7126aedbcce0c95a17936841fdddcf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002500","is_excluded":false,"label":"Abnormal cerebral white matter morphology","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4306926e56548a134813df760ad9f6fe6a45c49a0068407c182c0cb975c5c23c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0012402","is_excluded":false,"label":"Increased urine alpha-ketoglutarate concentration","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"53234bb1efb1d0f83968d2fd6c2e591d2edf703814375f7a8a559cf829d4ce57","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:6000468","is_excluded":false,"label":"Elevated CSF alpha-ketoglutarate concentration","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"634154f6ed08f98bb66d481c74f9f7897d8be2b65ea1967c024daad2bdefd44c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002344","is_excluded":false,"label":"Progressive neurologic deterioration","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7498b3351437916161c8b466f09dfbcc055faa687e3b86f8d48c01b847ce7000","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"75de04a6092744fd8bcebed8ccdab1b4f64bf5200dc193248efa892b5570398f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0012229","is_excluded":false,"label":"CSF pleocytosis","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8c2ecb7f2ddda9f4ae134a329a8d7e3383cb7be325675e096d819f152a430b20","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a1dc554c73121f8ae97b2fc1dca3d4758d97fceaa48ae0ccf3f32420ab390fed","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001310","is_excluded":false,"label":"Dysmetria","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b588d22d32accff4fc4b0da30e83db21bbdf2c75d0f4fb98db51edc08b11480c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"be2732e1a8e5ebc5295c6b3ba266f44313c9585bb7e0f1d63d535bde1bff5f0a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002329","is_excluded":false,"label":"Drowsiness","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c8ba2a974d689e4abc20a2e1cd0e4b80b8cca38bf9f06c8fb3a49b089c320ddd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0033092","is_excluded":false,"label":"Increased urine succinate level","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cfbcb0e76aa745f5f4d33970d35d7e105035376c6798e6e96fc1c6508b3029ca","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0034649","is_excluded":false,"label":"Elevated urine N-acetylaspartic acid level","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e9275794122574bff7707d8c9c70e4c6c57eeceea093b9f7a16bb3cf2258ad5f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618384","disease_name":"Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002490","is_excluded":false,"label":"Increased CSF lactate","onset_id":null,"reference":"PMID:30635937","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"leukoencephalopathy-acute-reversible-with-increased-urinary-alpha-ketoglutarate","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate"},"schemaVersion":1}